Development of a clinical decision tool to reduce diagnostic testing for primary aldosteronism in patients with difficult-to-control hypertension

Satisfactory tools to preclude low-risk patients from intensive diagnostic testing for primary aldosteronism (PA) are lacking. Therefore, we aimed to develop a decision tool to determine which patients with di...

Source: BMC Endocrine Disorders - April 29, 2020 Category: Endocrinology Authors: Monique E. A. M. van Kleef, Frank L. J. Visseren, Jan Westerink, Michiel L. Bots, Peter J. Blankestijn, Yolanda van der Graaf and Wilko Spiering Tags: Research article Source Type: research